Rituximab Treatment in Myasthaenia Gravis Report of two paediatric cases

Journal Title: Sultan Qaboos University Medical Journal - Year 2018, Vol 18, Issue 2

Abstract

Myasthaenia gravis (MG) is an autoimmune disease involving the postsynaptic receptors in the neuromuscular junction. Te condition is characterised by fatigable weakness of the skeletal muscles and is uncommon in children. Acetylcholinesterase inhibitors and immune-modifying medications are usually considered the mainstay of treatment. However, these medications have to be given on a lifelong basis so that patients remain in remission; furthermore, drug-related side-effects can have a major impact on quality of life. We report two paediatric cases who were treated for MG at the Sultan Qaboos University Hospital, Muscat, Oman, in 2007 and 2008, respectively. Rituximab was eventually administered to each patient after their condition failed to improve despite several years of standard treatment with acetylcholinesterase inhibitors and immune-modifying medications. Overall, rituximab resulted in complete remission in one case and signifcant clinical improvement in the other case.

Authors and Affiliations

Roshan Koul, Amna Al-Futaisi, Rana Abdelrahim, Renjith Mani, Reem Abdwani, Abdullah Al-Asmi

Keywords

Related Articles

Thyrotoxic Neuropathy A rare cause of acute flaccid paraplegia

Acute polyneuropathy is a rare manifestation of severe hyperthyroidism. We report a 22-year-old Omani male who presented to the Sohar Hospital, Sohar, Oman, in 2016 with acute-onset rapidly progressive flaccid arefle...

Causes of Stress and Coping Strategies Adopted by Undergraduate Health Professions Students in a University in the United Arab Emirates

Objectives: Tis study aimed to compare causes of stress and coping strategies adopted by a sample of undergraduate health-profession students at the Gulf Medical University, United Arab Emirates. Methods: An anonymous...

Rituximab Treatment in Myasthaenia Gravis Report of two paediatric cases

Myasthaenia gravis (MG) is an autoimmune disease involving the postsynaptic receptors in the neuromuscular junction. Te condition is characterised by fatigable weakness of the skeletal muscles and is uncommon in childr...

Clinical Outcomes and Counselling Issues regarding Partial Trisomy of Terminal Xp in a Child with Developmental Delay

Female carriers of balanced translocations involving an X chromosome and an autosome offer genetic counselling challenges. Tis is in view of the number of possible meiotic outcomes, but also due to the impact of X chr...

Download PDF file
  • EP ID EP29173
  • DOI -
  • Views 413
  • Downloads 16

How To Cite

Roshan Koul, Amna Al-Futaisi, Rana Abdelrahim, Renjith Mani, Reem Abdwani, Abdullah Al-Asmi (2018). Rituximab Treatment in Myasthaenia Gravis Report of two paediatric cases. Sultan Qaboos University Medical Journal, 18(2), -. https://europub.co.uk/articles/-A-29173